Metabolic reprogramming and circadian disruption drive cellular senescence. Discover how repurposing vutiglabridin to target ...

NKT therapy, agenT-797, delivers context-dependent immune reprogramming showing activation in cancer and anti-inflammatory benefit in ARDS — ...

hLife adopts format-free submission. Format-free submission means that, provided you include everything necessary for review ...

Early warning signs: Inflammation and genetic mutations can reprogram healthy glandular cells into precancerous states, setting the stage for adenocarcinoma formation. Molecular breakthroughs: ...

From studying microRNAs in embryonic stem cells to exploring exosomes in anti-tumor immunity, Blelloch illustrates how ...

GC Therapeutics (GCTx), a pioneering biotechnology company advancing the next generation of cell-based medicines through its TFome™ (Transcription-Factor-ome) induced pluripotent stem cell (iPSC) ...

Years before he conducted the research that would earn him a Nobel Prize in Physiology and Medicine, Shinya Yamanaka, MD, Ph.D., was a postdoctoral scientist at Gladstone Institutes, studying genes.

New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific collaboration with Biohub to develop optimized methodologies for deriving induced ...

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke Koike Supported by By Susan Dominus Why are babies born young? The most ...

Yuancheng Ryan Lu could barely breathe while he waited for his labmate to adjust the microscope focus. On the slide in front of them were the results of Lu’s latest attempt to turn back time for ...